Beroni Logo @ Dec 2019.png
Beroni Group Has Successfully Constructed and Purified 24 Types of Nanobodies for Detection and Treatment of COVID-19
August 04, 2020 09:30 ET | Beroni Group Limited
NEW YORK and SYDNEY, Australia, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused...
Beroni Logo @ Dec 2019.png
Beroni Group to Supply COVID-19 Antibody Test Kit to Japan
July 10, 2020 09:30 ET | Beroni Group Limited
NEW YORK and SYDNEY, Australia, July 10, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused...
Beroni Logo @ Dec 2019.png
Dr Richard Buchta Appointed as Director of Beroni Group
June 30, 2020 09:30 ET | Beroni Group Limited
NEW YORK and SYDNEY, Australia, June 30, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused...
Beroni Logo @ Dec 2019.png
Beroni Group Issues US$2.97 million of Convertible Notes to Fund Growth Plans
May 27, 2020 09:30 ET | Beroni Group Limited
NEW YORK and SYDNEY, Australia, May 27, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused...
Beroni Logo @ Dec 2019.png
Beroni Group R&D Team Identifies 24 Types of Nanobodies for Rapid Detection and Treatment of Coronavirus (COVID-19)
May 08, 2020 09:30 ET | Beroni Group Limited
- Granted Approval by China Ministry of Commerce to Export Detection Kits Globally -- Obtained CE Certification by European Union - NEW YORK and SYDNEY, Australia, May 08, 2020 (GLOBE NEWSWIRE)...
Beroni Logo @ Dec 2019.png
Beroni Group Included in List of Commercial Manufacturers and Laboratories Who Have Notified US FDA of Validated Serology Tests for COVID-19
April 03, 2020 09:30 ET | Beroni Group Limited
NEW YORK and SYDNEY, Australia, April 03, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise...
Beroni Logo @ Dec 2019.png
Beroni Group’s SARS-CoV-2 IgG/IgM Antibody Detection Kit Received CE Certification
April 03, 2020 09:30 ET | Beroni Group Limited
NEW YORK and SYDNEY, Australia, April 03, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise...
Beroni Logo @ Dec 2019.png
Beroni Group Announces Submission of Emergency Use Authorization to US FDA for its COVID-19 Rapid Test Detection Kit
March 26, 2020 09:30 ET | Beroni Group Limited
NEW YORK and SYDNEY, Australia, March 26, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise...
Beroni Logo @ Dec 2019.png
Beroni Group Advances Research and Development of Medical Solution for Coronavirus (COVID-19)
March 09, 2020 09:30 ET | Beroni Group Limited
- Cytological Experiments Commenced in March 2020 - - Clinical Trials to Commence in April 2020 - NEW YORK and SYDNEY, Australia, March 09, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF;...
Beroni Logo @ Dec 2019.png
Beroni Group Collaborates with Tianjin University to Develop Novel Solution for Coronavirus (COVID-19)
February 20, 2020 09:30 ET | Beroni Group Limited
NEW YORK and SYDNEY, Australia, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused...